Pact politics

High political drama marks climate negotiations as the European Union strives to ratify the Kyoto protocol without the US, world's biggest polluter

Playing safe

Nations finally draft a treaty to combat the use of toxic chemicals like DDT and PCBs, which are known for their damning health effects

In Obninsk there was a mausoleum

Nuclear power wants to pose as peace, sustainability. But to the world, it has always meant the bomb and danger. What are governments doing to …

Manipulating Research

Private funding has given a new meaning to scientific research today. With rising corporate research budgets, academic institutions are leaning …

Science and Technology - Briefs

Equity: the next frontier in climate talks

Women, children worst victims of indoor air pollution

Will Robert Zoellick make a better World Bank president?

News - In short

UNFCCC meet fails to secure emission commitments

Can we afford not to change?

One step forward, two steps back

Countries want to do little to keep global average temperature rise to below 2oC. The Warsaw climate talks have exposed this. A report by Uthra …

US says it will not extend commitment on climate mitigation efforts

Ambitions on reducing carbon emissions levels missing at CoP 18, say developing countries

The civil spring

Have an aggressive government and an overreaching judiciary curbed dissent?

Loud and unclear

Hindustan motors

Can India ever have car-free centres?

India reacts sharply to human development report

The China affair what it means to us

Care turns down US $46 million food aid

In short

Unmasking aerosols

Forget health impacts, tiny particles floating in the air are altering regional climates and affecting monsoon patterns and agricultural yield. …

COVID-19 unlockdown is a challenge and an opportunity at the same time

It will generate medium-term challenges but also presents an opportunity to accelerate the shift to more sustainable and equitable growth

Testing the CL route

Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs

Ethics on trial

Five per cent of the clinical trials conducted across the world will be in India by 2012. They are vital for confirming the efficacy of a new drug,…

Hold Up!

The stage seemed set for another climate meeting to serve the economic interests of the US better than the threat of global warming